End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 USD | +800.00% | +164.71% | -98.56% |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-98.56% | 2.58M | |
-20.55% | 10.67B | |
+43.76% | 3.22B | |
-36.01% | 2.09B | |
-17.21% | 2.04B | |
-29.86% | 1.46B | |
+17.94% | 1B | |
-4.37% | 734M | |
-36.83% | 391M | |
-46.84% | 379M |
- Stock Market
- Equities
- NVTA.Q Stock
- News Invitae Corporation
- Invitae : Morgan Stanley Adjusts Price Target on Invitae to $41 From $45, Maintains Equal-Weight Rating